Cystadane Powder, For Solution
Product Images NDC 52276-400

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cystadane (NDC 52276-400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Recordati Rare Diseases, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Betaine Anhydrous Structural Formula (Image 01)

Chemical structure diagram of betaine, the active ingredient in Cystadane, showing the molecular arrangement including a quaternary ammonium group and a carboxylate group.*

FDA Label Image

Recordati Rare Diseases Logo (Image 03)

FDA Label Image

Cystadane® Betaine Anhydrous For Oral Solution Logo (Image 04)

FDA Label Image

Cystadane (betaine Anhydrous) For Oral Solution Label (Image 05)

Label for Cystadane (betaine anhydrous) 1 gram powder for oral solution, 180 grams total. The label includes directions for preparation and administration, stating to shake the bottle, measure with the scoop provided, and mix with water, juice, milk, or formula. Manufactured by Recordati Rare Diseases, made in Germany. Contains storage instructions and caution to keep out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.